PsA Frequently Asked Questions (FAQs) | Otezla® (apremilast)
Indications
APPROVED USES Prescription Otezla®/Otezla XRTM (apremilast) is used for the treatment of:

Active Psoriatic Arthritis:

  • OTEZLA: Adult and pediatric patients 6 years of age and older and weighing at least 20 kg (44 lbs) with active psoriatic arthritis. Read more >
Approved Uses Prescription Otezla®/Otezla XRTM (apremilast) is used for the treatment of:

Active Psoriatic Arthritis:

  • OTEZLA: Adult and pediatric patients 6 years of age and older and weighing at least 20 kg (44 lbs) with active psoriatic arthritis.
  • OTEZLA XR: Adult and pediatric patients 6 years of age and older and weighing at least 50 kg (110 lbs) with active psoriatic arthritis.

Plaque Psoriasis:

  • OTEZLA/OTEZLA XR: Adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
  • OTEZLA: Pediatric patients 6 years of age and older and weighing at least 20 kg (44 lbs) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
  • OTEZLA XR: Pediatric patients 6 years of age and older and weighing at least 50 kg (110 lbs) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Oral Ulcers Associated with Behçet’s Disease:

  • OTEZLA/OTEZLA XR: Adult patients with oral ulcers associated with Behçet’s Disease. Read less >

Frequently asked questions

Whether you’re already on treatment or simply exploring your options, it’s normal to have questions. Here are answers to some of the most commonly asked questions.

What is Otezla
or Otezla Extended-Release

  • What is Otezla or Otezla Extended-Release?
    Example of Otezla (apremilast) pill

    Otezla is a prescription pill offered in a 30 mg twice-daily pill or 75 mg Extended-Release once-daily pill.

    It is approved to treat adults with active psoriatic arthritis, plaque psoriasis who are candidates for phototherapy or systemic therapy, and oral ulcers associated with Behçet’s Disease.

    It is also approved for children 6 years of age and older with active psoriatic arthritis or with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Otezla may be prescribed to pediatric patients weighing at least 44 lbs, while Otezla Extended-Release may be prescribed to pediatric patients weighing at least 110 lbs.

  • Is Otezla a biologic?
    PDE4 inhibitor

    No, Otezla is not a biologic. It is a phosphodiesterase 4 (PDE4) inhibitor. This means it reduces the activity of an enzyme called PDE4 inside the cells—which is then thought to reduce inflammation and plaque psoriasis symptoms. Learn more about how Otezla works.

Taking Otezla
or Otezla Extended-Release

  • What dosing options are available?

    Otezla is available as a 30 mg twice-daily pill or as a 75 mg Extended-Release once-daily pill.

    Talk to your doctor to explore which formulation is the right option for you.

  • Who can take Otezla Extended-Release pills?

    Otezla Extended-Release 75 mg pills are approved for:

    • Adult patients with: Plaque psoriasis who are candidates for phototherapy or systemic therapy; or active psoriatic arthritis (PsA) or oral ulcers associated with Behçet’s Disease
    • Pediatric patients 6 years of age and older and weighing at least 110 lbs with: Moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy; active psoriastic arthritis (PsA)

    Otezla Extended-Release pills are not recommended for patients with severe kidney disease.

    Talk to your doctor if you are currently taking Otezla 30 mg twice-daily and are interested in switching your prescription to Otezla Extended-Release once daily.

  • How do I take my prescription?
    Calendar

    Once prescribed, you can get started right away: with no blood work or routine lab testing required.*

    Your doctor may send you home with a 14-day treatment initiation pack. With this, you will slowly increase your treatment dose until you reach the recommended dose. This is known as titration.

    Once you have completed your titration pack, you will then continue with either your prescribed Otezla 30 mg twice-daily, or Otezla Extended-Release 75 mg once-daily.

    People with severe kidney disease will follow a different schedule for Otezla. Otezla Extended-Release tablets are not recommended for people with severe kidney disease.

    Be sure to take your medication as directed by your healthcare professional. Learn more by clicking here.

    *Once-daily Otezla Extended-Release dosing starts after initial titration with Otezla.

  • What if I miss a dose?

    If you miss a dose, contact your healthcare provider to determine the most appropriate next steps.

  • Can I crush, chew, or split the pills?

    This medication should be swallowed whole and should not be crushed, split or chewed.

  • What are the side effects of Otezla?

    The most common side effects include diarrhea, nausea, upper respiratory tract infection, tension headache, and headache. These are not all the possible side effects. Ask your doctor about other potential side effects.

    Tell your doctor about any side effect that bothers you or does not go away. Learn more about the side effects.

  • Are there certain medications I already take that could make my prescription less effective?

    Yes, so it’s important to discuss all the medications you’re currently taking with your doctor. It may help to compile a list, and bring it to your appointment. You can also ask a pharmacist if you should not take some medications with Otezla/Otezla Extended-Release.

  • How many people have taken Otezla?
    More than 1 million Otezla® (apremilast) patients

    Over 1 million people have been treated with Otezla globally,† and for
    over 10 years, doctors have been prescribing it.

    †Estimates of patients treated reflect global data since launch (Apr 2014-Mar 2024; US=59% of data). Calculations based on observed drug utilization parameters and number of units distributed. Utilization patterns change over time to best represent current markets.

  • Can I take my medication if I’m pregnant or planning to be?

    Tell your doctor if you are pregnant, planning to become pregnant, or planning to breastfeed. Your doctor can recommend the best treatment plan for you.

How Otezla works

  • How does Otezla work?
    Example of PDE4 inhibitor

    The exact way in which Otezla works is not completely understood. Research has shown that Otezla blocks the activity of an enzyme found inside cells called phosphodiesterase 4 (PDE4). PDE4 is believed to contribute to the inflammation that comes with plaque psoriasis. By blocking PDE4, Otezla is thought to help reduce inflammation inside the body and lessen psoriatic arthritis symptoms. Learn more details about how Otezla works, or watch the video below.

Otezla results

  • When can I expect to see results with Otezla?

    Everyone’s experience is different, but after just 4 months, Otezla was proven to reduce the joint swelling, tenderness, and pain of psoriatic arthritis, and to improve the ability to perform physical activities in some people. See how Otezla could help with the symptoms of psoriatic arthritis.

    Use this guide to discuss your results with your doctor.

  • Why do I need to take Otezla if my symptoms have improved?

    Even though you may be feeling better, plaque psoriasis doesn't go away. Otezla should be taken as prescribed, at the same times every day. Talk to your doctor if you experience any side effects.

Getting Otezla

  • How will I receive my Otezla prescription?
    Delivery

    Your Otezla prescription will be delivered to you each month by a specialty pharmacy. Not sure what that means? Specialty pharmacies operate a lot like retail pharmacies, but they provide additional services and deliver your medication right to your door. Your specialty pharmacy will coordinate the delivery of your Otezla prescription and offer support, including access to pharmacists, refill reminders when you’re running low on your medication, and more.

    Patient roadmap

    Visit the Getting Your Prescription page for more details.

  • Is Otezla covered by my insurance?
    Insurance coverage questions

    Learn more about the ways Amgen® SupportPlus can help you access your prescribed medication. Please call 1-844-4OTEZLA (1-844-468-3952). Someone is available 8AM – 8PM ET, Monday – Friday.

    Find out more about Amgen SupportPlus.

  • Where can I find help paying for Otezla?
    insurance card

    Commercially insured? Eligible patients can enroll in the Otezla Co-Pay Program‡ to pay as little as $0 for Otezla.

    Eligibility criteria and program maximums apply. See AmgenSupportPlus.com/copay-terms for full Terms and Conditions.

    Medicaid, Medicare, uninsured, or underinsured? Unfortunately, you are not eligible to enroll in the Otezla Co-Pay Program. You may find the resources§ below helpful. If you have any other questions, please call 1-844-4OTEZLA (1-844-468-3952).

    By clicking the links below you will be leaving the Otezla website.

    If you have Medicare, please click here.
    If you have Medicaid, click here.
    If you are uninsured or underinsured, click here.

    §Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofit’s criteria. Amgen has no control over these programs and provides information as a courtesy only.

  • What is Co-Pay and the Otezla Co-Pay** Program?

    A co-pay (or co-payment) is a flat fee that is paid each time a patient goes to a doctor or fills a prescription. The Otezla Co-Pay Program helps reduce that fee.

    Patients with commercial insurance (self-purchased or through an employer) usually pay what is called the “out-of-pocket” cost for Otezla. This is the amount they owe after their insurance coverage has kicked in and any co-pays or deductibles have been applied.

    Whether you were just prescribed Otezla or have been on Otezla, you can enroll in the Otezla Co-Pay Program Program today. Once you have enrolled, you’ll receive a digital co-pay card via email. Share your co-pay information with your specialty pharmacy to begin lowering your out-of-pocket costs. Eligible, commercially insured patients may pay as little as $0 per month for Otezla.

    The pharmacy can apply the Otezla Co-Pay Program benefit (automatically) each month up to the annual maximum benefit of the co-pay program.

    **Eligibility criteria and program maximums apply. See AmgenSupportPlus.com/copay-terms for full Terms and Conditions.

  • How do I enroll in the Otezla Co-Pay Program?

    Signing up is simple, just fill out the form at Otezla.com/enroll, and if you’re eligible, you’ll automatically be enrolled. Once you have enrolled, you’ll receive a digital co-pay card via email. Share the co-pay information with your specialty pharmacy to begin lowering your out-of-pocket costs.

    The Otezla Co-Pay Card is available to eligible patients with commercial insurance (usually self-purchased or through an employer) regardless of income level.

  • How long does enrollment in the Otezla Co-Pay Program last?

    Re-enrollment in the program is required at regular intervals. You may continue in the program as long as you re-enroll as required by Amgen and continue to meet all of the program’s eligibility requirements during participation in the program.

    If at any point your insurance changes, your enrollment in the program may be
    re-evaluated. You must continue to meet the program’s eligibility requirements to continue receiving benefits.

About psoriatic arthritis
and plaque psoriasis

  • What is psoriatic arthritis?
    Joint

    Psoriatic arthritis is an autoimmune disease. It’s a type of arthritis that can affect anyone, but sometimes develops in people with psoriasis. Some of the symptoms of psoriatic arthritis include joint swelling, tenderness, and pain. Learn more about what causes psoriatic arthritis.

  • What is plaque psoriasis?

    Plaque psoriasis is an autoimmune disease that starts inside the body, but appears on the skin as red, scaly plaques, which can also itch. Find out more about what causes plaque psoriasis.

  • Is there a relationship between psoriatic arthritis and plaque psoriasis?

    Many people with psoriatic arthritis have symptoms of plaque psoriasis too, like nail changes, or uncomfortable, flaky patches on their skin. If you are experiencing any of these symptoms, please talk to your doctor.

  • Where can I find more information about psoriatic arthritis?

    Here are some helpful websites for psoriatic arthritis information and support:

Resources and support

  • Are there any resources to help me when I start treatment?
    Amgen® SupportPlus Representative

    Your doctor is always your best resource for any questions you might have about treatment, but we can help you find more information about getting started once prescribed.
    Call 1-844-4OTEZLA (1-844-468-3952) to speak with an Amgen® SupportPlus Representative.

  • How can I hear from others about their decision to start Otezla?
    Two talking bubbles

    You’ll find stories from people living with psoriatic arthritis and currently taking Otezla on our Patient Stories page.

IMPORTANT SAFETY INFORMATION

Do not take Otezla 30 mg tablets or Otezla XR 75 mg extended-release tablets if you are allergic to apremilast or to any of the ingredients in Otezla/Otezla XR

Otezla/Otezla XR can cause serious side effects, including:

  • Allergic reactions, sometimes severe. Stop using Otezla/Otezla XR and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
  • Severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla/Otezla XR may increase the risk of complications from having severe diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.
  • Depression. In clinical studies, some patients reported depression or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla/Otezla XR, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla/Otezla XR.
  • Weight loss. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla/Otezla XR. For children 6 years of age or older, their doctor should monitor their growth (height and weight). If they are not growing or gaining weight as expected, their doctor will decide if they should continue taking Otezla/Otezla XR.

Some medicines may make Otezla/Otezla XR less effective and should not be taken with Otezla/Otezla XR. Tell your doctor about all the medicines you take, including prescription and non-prescription medicines.

The most common side effects include diarrhea, nausea, upper respiratory tract infection, tension headache, and headache. These are not all the possible side effects with Otezla/Otezla XR. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.

Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.

Please click here for the Full Prescribing Information for Otezla/Otezla XR.

APPROVED USES

Prescription Otezla® /Otezla XRTM (apremilast) is used for the treatment of:

Active Psoriatic Arthritis:

  • OTEZLA: Adult and pediatric patients 6 years of age and older and weighing at least 20 kg (44 lbs) with active psoriatic arthritis
  • OTEZLA XR: Adult and pediatric patients 6 years of age and older and weighing at least 50 kg (110 lbs) with active psoriatic arthritis.

Plaque Psoriasis:

  • OTEZLA/OTEZLA XR: Adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.
  • OTEZLA: Pediatric patients 6 years of age and older and weighing at least 20 kg (44 lbs) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
  • OTEZLA XR: Pediatric patients 6 years of age and older and weighing at least 50 kg (110 lbs) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Oral Ulcers Associated with Behçet’s Disease:

  • OTEZLA/OTEZLA XR: Adult patients with oral ulcers associated with Behçet’s Disease.

IMPORTANT SAFETY INFORMATION

Do not take Otezla 30 mg tablets or Otezla XR 75 mg extended-release tablets if you are allergic to apremilast or to any of the ingredients in Otezla/Otezla XR.

Otezla/Otezla XR can cause serious side effects, including:

  • Allergic reactions, sometimes severe. Stop using Otezla/Otezla XR and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.